Healthcare - Biotechnology - NASDAQ - US
$ 0.2283
-3.14 %
$ 10.9 M
Market Cap
-0.17
P/E
BALANCE SHEET
17.7 M
ASSETS
17.6 M
LIABILITIES
123 K
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Mustang Bio, Inc.
| Current Assets | 11.3 M |
| Cash & Short-Term Investments | 6.23 M |
| Receivables | 3.88 M |
| Other Current Assets | 1.23 M |
| Non-Current Assets | 6.4 M |
| Long-Term Investments | 750 K |
| PP&E | 4.81 M |
| Other Non-Current Assets | 833 K |
| Current Liabilities | 15.4 M |
| Accounts Payable | 6.32 M |
| Short-Term Debt | 1.04 M |
| Other Current Liabilities | 8.01 M |
| Non-Current Liabilities | 2.25 M |
| Long-Term Debt | 1.98 M |
| Other Non-Current Liabilities | 270 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 6.2 | 75.7 | 109.6 | 97.8 | 61.4 | 16.5 | 35.0 | 27.5 | 0 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 17.6 | 26.0 | 0 | 0 |
| Receivables | 3.9 | 0.3 | 50 K | 15 K | 19 K | 37 K | 0.1 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.2 | 3.2 | 2.0 | 1.7 | 1.6 | 1.0 | 0.3 | 0 | 0 |
| Total Current Assets | 11.3 | 78.9 | 111.7 | 99.5 | 63.1 | 35.1 | 61.4 | 27.5 | 0 |
| PP&E | 4.8 | 12.3 | 12.1 | 9.1 | 9.1 | 6.9 | 1.4 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0.8 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 0 | 0 |
| Other Long Term Assets | 0.8 | 0.3 | 0.4 | 0.2 | 0.2 | 0.3 | 0.3 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 17.7 | 92.4 | 125.2 | 109.9 | 73.4 | 42.8 | 63.5 | 27.5 | 0 |
| LIABILITIES | |||||||||
| Accounts Payable | 6.3 | 6.8 | 3.5 | 3.5 | 1.9 | 1.4 | 3.5 | 0.7 | 15 K |
| Short Term Debt | 1.0 | 1.2 | 0.7 | 0.6 | 1.8 | 0 | 0 | 0.3 | 3.6 |
| Other Current Liabilities | 8.0 | 7.1 | 6.6 | 5.4 | 4.1 | 4.2 | 0.1 | 2.2 | 0.5 |
| Total Current Liabilities | 15.4 | 15.1 | 10.8 | 9.5 | 7.8 | 5.6 | 3.6 | 3.2 | 4.1 |
| Long Term Debt | 2.0 | 30.8 | 1.7 | 1.9 | 14.0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | (27.7) | (0.3) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0.7 | 50 K | 0 | 0 |
| Total Liabilities | 17.6 | 46.1 | 12.8 | 11.5 | 21.8 | 6.4 | 3.7 | 3.2 | 4.1 |
| EQUITY | |||||||||
| Common Stock | 1 K | 11 K | 9 K | 7 K | 4 K | 3 K | 3 K | 2 K | 1 K |
| Retained Earnings | (381.0) | (329.4) | (251.8) | (185.5) | (125.5) | (79.1) | (48.4) | (17.1) | (4.5) |
| Other Accumulative Comprehensive Income/Loss | 0.6 | 1.1 | 4.3 | 7.9 | 4.9 | 2.1 | 9.6 | 4.4 | 0 |
| Total Equity | 0.1 | 46.3 | 112.4 | 98.4 | 51.7 | 36.4 | 59.8 | 24.3 | (4.1) |
| Total Liabilities and Equity | 17.7 | 92.4 | 125.2 | 109.9 | 73.4 | 42.8 | 63.5 | 27.5 | 0 |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 8.6 | 6.9 | 5.9 | 3.5 | 2.4 | 1.8 | 1.7 | 1.7 | 0.7 |